Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder. Eur Arch Psychiatry Clin Neurosci. 2026 276(2):761-770. Epub 2025 Mar 12.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study. Transl Psychiatry. 2026 16(1):226. Epub 2026 Mar 31.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study. Lancet Reg Health Eur. 2026 65:101658.
Motka F, Tan H, Vollstädt-Klein S, Bertsch K, Wittekind CE. The effects of approach bias modification on smoking cue-reactivity in individuals who smoke: A randomized controlled fMRI study. Sci Rep. 2026 16(1)
Wolf ND, Schmitgen MM, Henemann GM, Haage S, Bach P, Koenig J, Wolf RC. Sex-specific neural responses to smartphone cues in young adults. Biol Sex Differ. 2026 17(1):39. Epub 2026 Jan 31.